This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
7bcq
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==ASCT2 in the presence of the inhibitor Lc-BPE (position "up") in the outward-open conformation.== | ==ASCT2 in the presence of the inhibitor Lc-BPE (position "up") in the outward-open conformation.== | ||
| - | <StructureSection load='7bcq' size='340' side='right'caption='[[7bcq]]' scene=''> | + | <StructureSection load='7bcq' size='340' side='right'caption='[[7bcq]], [[Resolution|resolution]] 3.43Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7BCQ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7BCQ FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[7bcq]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7BCQ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7BCQ FirstGlance]. <br> |
| - | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7bcq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7bcq OCA], [https://pdbe.org/7bcq PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7bcq RCSB], [https://www.ebi.ac.uk/pdbsum/7bcq PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7bcq ProSAT]</span></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=TG2:4-(4-phenylphenyl)carbonyloxypyrrolidine-2-carboxylic+acid'>TG2</scene></td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7bcq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7bcq OCA], [https://pdbe.org/7bcq PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7bcq RCSB], [https://www.ebi.ac.uk/pdbsum/7bcq PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7bcq ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| + | == Function == | ||
| + | [[https://www.uniprot.org/uniprot/AAAT_HUMAN AAAT_HUMAN]] Sodium-dependent amino acids transporter that has a broad substrate specificity, with a preference for zwitterionic amino acids. It accepts as substrates all neutral amino acids, including glutamine, asparagine, and branched-chain and aromatic amino acids, and excludes methylated, anionic, and cationic amino acids (PubMed:8702519). Through binding of the fusogenic protein syncytin-1/ERVW-1 may mediate trophoblasts syncytialization, the spontaneous fusion of their plasma membranes, an essential process in placental development (PubMed:10708449, PubMed:23492904).<ref>PMID:10708449</ref> <ref>PMID:23492904</ref> <ref>PMID:8702519</ref> (Microbial infection) Acts as a cell surface receptor for Feline endogenous virus RD114.<ref>PMID:10051606</ref> <ref>PMID:10196349</ref> (Microbial infection) Acts as a cell surface receptor for Baboon M7 endogenous virus.<ref>PMID:10196349</ref> (Microbial infection) Acts as a cell surface receptor for type D simian retroviruses.<ref>PMID:10196349</ref> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | ASCT2 (SLC1A5) is a sodium-dependent neutral amino acid transporter that controls amino acid homeostasis in peripheral tissues. In cancer, ASCT2 is up-regulated where it modulates intracellular glutamine levels, fueling cell proliferation. Nutrient deprivation via ASCT2 inhibition provides a potential strategy for cancer therapy. Here, we rationally designed stereospecific inhibitors exploiting specific subpockets in the substrate binding site using computational modeling and cryo-electron microscopy (cryo-EM). The final structures combined with molecular dynamics simulations reveal multiple pharmacologically relevant conformations in the ASCT2 binding site as well as a previously unknown mechanism of stereospecific inhibition. Furthermore, this integrated analysis guided the design of a series of unique ASCT2 inhibitors. Our results provide a framework for future development of cancer therapeutics targeting nutrient transport via ASCT2, as well as demonstrate the utility of combining computational modeling and cryo-EM for solute carrier ligand discovery. | ||
| + | |||
| + | Rational design of ASCT2 inhibitors using an integrated experimental-computational approach.,Garibsingh RA, Ndaru E, Garaeva AA, Shi Y, Zielewicz L, Zakrepine P, Bonomi M, Slotboom DJ, Paulino C, Grewer C, Schlessinger A Proc Natl Acad Sci U S A. 2021 Sep 14;118(37). pii: 2104093118. doi:, 10.1073/pnas.2104093118. PMID:34507995<ref>PMID:34507995</ref> | ||
| + | |||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
| + | <div class="pdbe-citations 7bcq" style="background-color:#fffaf0;"></div> | ||
| + | == References == | ||
| + | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Bonomi M]] | + | [[Category: Bonomi, M]] |
| - | [[Category: Garaeva | + | [[Category: Garaeva, A A]] |
| - | [[Category: Garibsingh | + | [[Category: Garibsingh, R A]] |
| - | [[Category: Grewer C]] | + | [[Category: Grewer, C]] |
| - | [[Category: Ndaru E]] | + | [[Category: Ndaru, E]] |
| - | [[Category: Paulino C]] | + | [[Category: Paulino, C]] |
| - | [[Category: Schlessinger A]] | + | [[Category: Schlessinger, A]] |
| - | [[Category: Shi Y]] | + | [[Category: Shi, Y]] |
| - | [[Category: Slotboom | + | [[Category: Slotboom, D J]] |
| - | [[Category: Zielewicz L]] | + | [[Category: Zielewicz, L]] |
| + | [[Category: Cancer metabolism]] | ||
| + | [[Category: Cryo-em]] | ||
| + | [[Category: Glutamine deprivation]] | ||
| + | [[Category: Homology modeling]] | ||
| + | [[Category: Membrane protein]] | ||
| + | [[Category: Solute carrier transporter]] | ||
Current revision
ASCT2 in the presence of the inhibitor Lc-BPE (position "up") in the outward-open conformation.
| |||||||||||
